https://io.nihr.ac.uk/techbriefings/olorofim-for-invasive-fungal-infections/
Olorofim for invasive fungal infections - NIHR Innovation Observatory
Nov 8, 2024 - Olorofim is currently in development for the treatment of invasive fungal infections caused by rare moulds. Scedosporiosis (including lomentosporiosis) is an...
invasive fungal infectionsolorofimnihrinnovationobservatory
https://stuup.ir/%D9%81%D9%86%D8%A7%D9%88%D8%B1%DB%8C/%D8%AF%D8%B1%D9%85%D8%A7%D9%86-%D8%B9%D9%81%D9%88%D9%86%D8%AA%D9%87%D8%A7%DB%8C-%D9%82%D8%A7%D8%B1%DA%86%DB%8C-%D9%85%D9%82%D8%A7%D9%88%D9%85-%D8%A8%D8%A7-olorofim/
درمان عفونتهای قارچی مقاوم با Olorofim | استارتآپ F2G - آکادمی استو آپ
Apr 19, 2023 - بررسی عوامل ضد قارچ جدید و درمانهای مربوطه | معرفی داروی Olorofim از عوامل ضدقارچ جدید که محصول شرکت F2G است.
olorofim
https://sofinnovapartners.com/news/f2g-usd70-million-financing-advance-development-commercialization-new
F2G raises $70M to commercialize antifungal olorofim — Sofinnova Partners
Aug 4, 2022 - F2G raises $70M co-led by Forbion and Sofinnova to advance development and US commercialization of olorofim, a novel antifungal for rare mold infections.
raisescommercializeantifungalolorofimsofinnova